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  INTRODUCTION 
  Understanding the mechanisms that regulate mucus hyper-
production and hypersecretion in respiratory diseases is criti-
cal for developing new therapeutic medications to use against 
inflammation. Although the importance of MUC5AC and 
MUC8 during airway inflammation has been emphasized in 
our previous studies,  1 – 3   the negative regulatory mechanisms 
that can decrease their expressions in the airway remain 
unclear. Uncontrolled mucin hyperproduction and hyper-
secretion can increase morbidity and mortality by obstructing 
mucociliary clearance and air flow.  4 – 6   Thus,  clarification  of 
the intracellular mechanism underlying the negative regula-
tion of cytokine-induced MUC5AC overproduction could 
provide important clues toward understanding airway mucous 
hypersecretion. 
 c-E26 transformation-specific (Ets) 1 is a member of a family 
of transcription factors that have important roles in biologi-
cal processes.  7   To date, more than 25 mammalian Ets family 
members have been characterized and are known to control 
important biological processes including cellular proliferation, 
differentiation, lymphocyte development, and activation, and 
transformation via the recognition of a GCA core sequence in 
the promoter or enhancer of target genes, and mutual regulation 
of the pro- and anti-inflammatory T  H 1  response. 8   The  prob-
able dual function of c-Ets1 in the regulation of cellular phe-
nomena has been suggested by the finding that c-Ets1 might be 
essential for the initiation and progression of T  H 1-cell-mediated 
macrophages. This activation occurs by controlling the expres-
sion of several inflammatory cytokines / chemokines.  9  There are 
protein  –  protein interactions that are involved in every step of 
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intracellular signaling, transcriptional transactivity regulation, 
and transcription factors turnover.  10   Therefore, we examined 
the role of c-Ets1 in a negative regulatory mechanism facilitated 
by disrupting the protein – protein (or transcription factor – tran-
scription factor) interaction on the   MUC5AC   promoter. 
  Reactive oxygen species (ROS) are induced by pro-
 inflammatory cytokines such as interleukins and tumor necrosis 
factor, during atherosclerosis.  11  Superoxide anions are produced 
in vascular tissue by xanthine oxidases, cyclooxygenases, and 
NADPH oxidases (NOX).  12   NAD(P)H oxidases are the major 
sources of superoxide in vascular cells, and are essential in 
physiological responses and pathological states. The former 
includes cell growth, cell migration, and modification of the 
extracellular matrix, and the pathological states are associated 
with uncontrolled growth and inflammation, such as in athero-
sclerosis.  13   Until now, seven homologs of gp91  phox   (NADPH 
oxidase; NOX2), the core component of NOX, have been iden-
tified in various nonphagocytic cells, including NOX1, NOX3, 
NOX4, NOX5, DUOX1, and DUOX2.  14   Of these, NOX4 is 
strongly expressed in endothelial cells.  15  Ushio-Fukai 16  showed 
that while ROS induces Ets-1 expression, the activated Ets-1 
increases the expression of ROS-generating enzymes. The aims 
of this study were as follows: (1) characterize the function of 
c-Ets1 in interleukin (IL)-1  -induced  MUC5AC  gene expression 
  in vitro  and  in vivo ; (2) identify the mechanism by which c-Ets1 
inhibits IL-1    -induced mucus overexpression; and (3) identify 
how ROS, produced by NADPH oxidase, influences the function 
of c-Ets-1 in IL-1   -induced  MUC5AC  overexpression.   
  RESULTS   
  NF-     B and CREB interact in the regulation of the IL-1     -
dependent   MUC5AC   gene expression in the human airway 
epithelial cells (NCI-H292) 
  To determine whether NF-    B activation is involved in the 
nuclear signaling of IL-1   -induced   MUC5AC   gene expression, 
we performed Western blotting with several phospho-specific 
antibodies. Alterations were seen in the phosphorylation status 
of i   B,  NF-   B, and cAMP response element-binding protein 
(CREB) after IL-1     treatment, but no expression changes were 
observed for NF-    B, CREB, or CREB-binding protein (CBP) 
(  Figure 1a ). As a result, we hypothesized that the interaction of 
NF-    B with CREB may form a ternary complex with CBP and 
DNA to affect  MUC5AC  gene expression in IL-1  -induced sign-
aling. To test our hypothesis, we performed an immunoprecipita-
tion assay after the IL-1   treatment. CBP was able to bind to the 
NF-   B after IL-1   treatment ( Figure 1b ), resulting in the forma-
tion of CREB-CBP-NF-  B to induce physiological phenomena. 
Interestingly, CREB was unable to bind to the NF-  B regardless 
of IL-1     treatment  ( Figure 1b  , top panel), whereas activated 
CREB bound to NF-  B in a time-dependent manner ( Figure 1b , 
bottom panel). Moreover, we used small interfering RNA 
(siRNA) constructs of CREB and NF-    B to examine whether 
the correlation between the physical interactions of CREB with 
NF-    B increases the transcriptional activity of the   MUC5AC  
gene. We found that inhibition of either CREB or NF-   B  sup-
pressed IL-1   -induced   MUC5AC   gene  expression  ( Figure 1c ). 
Both the CREB and NF-    B siRNA may have an additive func-
tion in the suppression of  MUC5AC  gene expression. These find-
ings indicate that the interaction of NF-    B with CREB may be 
necessary for IL-1  -induced  MUC5AC  transcription in human 
airway  epithelial  cells.   
  c-Ets1 transcription factor functions as a suppressor in IL-1     -
induced   MUC5AC   transcription 
  To identify the IL-1    -responsive region within the   MUC5AC  
promoter, NCI-H292 cells were transiently transfected with 
various deletion mutants and were treated with IL-1     for 
24   h.  IL-1    selectively increased the luciferase activity of 
the      −    929 /     −    1  region  of  the   MUC5AC   promoter, whereas the 
IL-1   -induced luciferase activity of the     −    950 /     −    1 region of the 
  MUC5AC   promoter was not affected. This finding indicates 
that  the      −    950 /     −    929  region  of  the   MUC5AC   promoter may be 
necessary for its response to IL-1     as a suppressor (  Figure 2a ). 
Interestingly,  there  is  no  CRE  site  in  the      −    950 /     −    929  region. 
This finding suggests that a transcription factor other than 
CREB may have a crucial role in   MUC5AC   transcription. 
            Figure 1                        Interleukin (IL)-1     induces the interaction of NF-    B with 
cAMP response element-binding protein (CREB) to enhance   MUC5AC   
gene expression in NCI-H292 cells. (  a  ) Confluent and quiescent NCI-
H292 cells were treated with IL-1     (10    ng    ml        −      1  ) for the indicated times, 
then lysates were harvested and analyzed by Western blot using several 
antibodies. Total NF-   B and CREB-binding protein (CBP) were used 
as loading controls. (  b  ) Cells were treated for the indicated times (min) 
and total lysates were then immunoprecipitated with anti-CREB, CBP, or 
phospho-CREB antibody, and blotted with anti-p65 antibody. IgG bands 
were used as a loading control. IP, immunoprecipitation. (  c  ) After cells 
were transfected with the small interfering RNA constructs of p65, CREB, 
or both, cells were treated with IL-1     for 24    h before the collection of 
total RNA for real-time quantitative real-time PCR.   *    P        <      0.05 compared 
with the control and   *    *    P        <      0.05 compared with IL-1     treatment only. The 
figures are representative of three independent experiments.   MucosalImmunology | VOLUME 5 NUMBER 2 | MARCH 2012   209
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We used the TFSEARCH Ver. 1.3 database (  http://www.cbrc.
jp/research/db/TFSEARCH.html ) to identify the IL-1  -respon-
sive   cis  -element in the   MUC5AC   promoter, and this search 
strategy  identified  a  candidate,  c-Ets1  (score    =    91.2;  threshold: 
90.0).  9   To further investigate whether c-Ets1, which was found 
within  the   – 938 /  – 930  region  of  the   MUC5AC   promoter, might 
act as a   cis   element,  cotransfection  with  the      −    950 /     −    1  reporter 
construct and either wild-type c-Ets1 expression construct or 
siRNA-c-Ets1 construct was performed to determine its effect 
on   MUC5AC   transcription activity. Wild-type c-Ets1 did not 
affect the luciferase activity of     −    950 /     −    1 region of the MUC5AC 
promoter, whereas the siRNA-c-Ets1 increased the activity 
(  Figure 2b  ). Moreover, we examined whether c-Ets1 acts as a 
suppressor. Three mutant constructs were generated to repre-
sent the selective mutagenesis of the c-Ets1-binding site. Only 
the     −    938 mutant construct increased the responsiveness of the 
wild-type  MUC5AC  promoter construct ( Figure 2c ). However, 
the     −    935 and  – 932 mutant constructs were able to suppress luci-
ferase activity. These results suggest that the c-Ets1 (    −    938 /     −    930 
region) in the regulatory region of the  MUC5AC  promoter may 
be critical for IL-1  -induced suppression of  MUC5AC  transcrip-
tional  activity.   
  c-Ets1 can dissociate the interaction of NF-     B with CREB to 
suppress IL-1     -induced   MUC5AC   gene expression 
  To further investigate the effect of the IL-1     on c-Ets1 activ-
ity, cells were treated with IL-1     in a time-dependent manner, 
and c-Ets1 phosphorylation was analyzed by Western blot using 
a specific antibody against phosphorylated c-Ets1 (pSer282). 
c-Ets1 was phosphorylated 30     min after IL-1     treatment, and 
this persisted for up to 60   min ( Figure 3a ). To examine whether 
c-Ets1 affects IL-1   -induced   MUC5AC   gene expression, tran-
sient transfection with a plasmid construct encoding either 
wild-type c-Ets1 or siRNA-c-Ets1 was performed (  Figure 3b ). 
The wild-type c-Ets1 suppressed IL-1  -induced  MUC5AC  gene 
expression, whereas siRNA-c-Ets1 upregulated   MUC5AC   gene 
expression, demonstrating that c-Ets1 may have a suppressive 
role in IL-1  -induced  MUC5AC  gene expression in NCI-H292 
cells. We performed electrophoretic mobility shift assay experi-
ments using nuclear extracts from NCI-H292 cells after IL-1    
treatment to further determine whether c-Ets1 directly affects 
the IL-1    -induced interaction of CREB with the CRE of the 
  MUC5AC   promoter. 5   For electrophoretic mobility shift assay, 
oligonucleotides corresponding to CRE-specific sequences in 
the  MUC5AC  promoter region  – 878 to  – 871 (5  -AGAGATTGC
C TGACTTGA AGAGCTAG-3  ) were synthesized. The activity 
of  MUC5AC -specific CRE increased remarkably in response to 
IL-1     ( Figure 3c  ). However, overexpressed c-Ets1 dissociated 
the interaction of CREB with the CRE site of the  MUC5AC  pro-
moter, whereas siRNA-c-Ets1 did not have such an effect. To 
distinguish any specific CRE-binding complexes, competition 
analysis was performed using 50-fold excesses of non-radio-
labeled (cold) CRE oligonucleotide. The specific band was selec-
tively inhibited by the cold-CRE oligonucleotide, indicating that 
overexpressed c-Ets1 functions as a suppressor by disrupting the 
interaction of activated CREB with either a   cis -acting  element, 
CRE, or another transcription factor(s) in the   MUC5AC   pro-
moter. Furthermore, to examine whether overexpressed c-Ets1 
affects the interaction of NF-    B with CREB to regulate IL-1   -
induced  MUC5AC  gene expression, we performed an immuno-
precipitation assay with anti-p65 IgG in c-Ets1-overexppressed 
cells ( Figure 3d ). Overexpressed c-Ets1 inhibited the interaction 
of CREB with NF-   B  after  IL-1    treatment, whereas siRNA-
c-Ets1 did not affect the protein complex, indicating that c-Ets1 
dissociated  the  CREB – NF-   B complex to attenuate the IL-1   -
induced physiological phenomena. These results are noteworthy 
        Figure 2                        Interleukin (IL)-1    -induced   MUC5AC   transcription was 
downregulated by the   cis  -acting c-Ets1 regulatory motif in NCI-H292 
cells. (  a  ) The cells were transfected with several luciferase reporter 
constructs encoding the   MUC5AC   promoter and treated with IL-1     
(10    ng    ml        −      1  ) for 24    h. Cell lysates were analyzed with a reporter assay 
according to the manufacturer  ’  s instructions.   *    P        <      0.05 compared with 
the       −      950  /        −      1 reporter construct. (  b  ) The cells were cotransfected with 
pGL3B::MUC5AC       −      950  /        −      1 and either the wild-type c-Ets1 expression 
construct or the small interfering RNA-c-Ets1 construct, and then treated 
with IL-1     (10    ng    ml        −      1  ) for 24    h.   *    P        <      0.05 compared with the       −      950  /        −      1 
reporter construct. (  c  ) Site-directed mutagenesis was carried out to 
generate the construct c-Ets1-binding site mutants as indicated. After 
treatment with IL-1     for 24    h, cell lysates were harvested. Displayed 
luciferase activities are shown after correction for transfection efficiency 
using the     -galactosidase activity of the cell lysates. Values shown are 
mean  ±  s.d. of experiments performed in triplicate.   *    P        <      0.05 compared 
with the wild-type reporter construct.   210  VOLUME 5 NUMBER 2 | MARCH 2012 | www.nature.com/mi
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because several reports have shown that c-Ets1 can bind to 
CBP  /  p300 but not to CREB.  17 – 19   Thus, our results suggest that 
c-Ets1 may have a suppressive role in IL-1  -induced  MUC5AC  
gene expression by negatively regulating the interaction of NF-
   B  with  CREB.   
  c-Ets1 inhibits IL-1     -induced mucous metaplasia, cell 
populations, and inflammatory proteins in mouse lungs 
  First, we examined whether the sh-c-Ets1 virus suppressed 
endogenous c-Ets1 protein levels. After viral infection into the 
right nostril of the mice, we verified that these viruses had well-
expressed coding proteins (  Figure 4a  ). In order to investigate 
whether IL-1   -induced   MUC5AC   gene expression might be 
regulated by c-Ets1  in vivo  as well as  in vitro , tracheotomies were 
performed to instill IL-1     into either control or virus-infected 
mice. IL-1  -induced  MUC5AC  gene expression was dramatically 
decreased in the mice infected with the virus expressing wild-
type c-Ets1 compared with those infected with the virus express-
ing sh-c-Ets1 (  Figure 4b  ). Periodic acid-schiff (PAS) staining, 
which was achieved by inducing mucous metaplasia with IL-1   
treatment in viruses-infected mice, was used to determine 
whether c-Ets1 acts as a negative regulator of the mucin granule 
exocytic complex during IL-1  -induced inflammation. The lungs 
from the infected mice were sectioned and stained with PAS. 
The airways of the IL-1  -instilled mice were found to be highly 
metaplastic, as they stained strongly with PAS (  Figure 4cii ). 
However, wild-type c-Ets1 overexpression inhibited IL-1   -
induced mucous metaplasia (  Figure 4ciii  ) whereas sh-RNA-c-
Ets1 had no effect ( Figure 4civ ). Inflammation is characterized 
by infiltration of eosinophilic leukocytes and T-helper type 2 
lymphocytes.  20   Eosinophils were the main constituent inflam-
matory cells in mice infected with viruses expressing either wild-
type or shRNA-c-Ets1 that were treated with IL-1   .  However, 
IL-1    -induced eosinophil production was not significantly 
higher in mice infected with virus expressing either wild-type 
or sh-RNA-c-Ets1 compared with wild-type mice (data not 
shown). Mice infected with virus-expressing sh-RNA-c-Ets1 had 
more lymphocytes, neutrophils, alveolar macrophages (AMs), 
and total protein levels in bronchoalveolar lavage (BAL) fluid, 
whereas those infected with virus expressing wild-type c-Ets1 
had significantly decreased levels of such markers, compared 
with the IL-1  -instilled mice ( Figure 4d ). However, after IL-1   
treatment, the total cell numbers peaked on day 7 in wild-type 
mice and declined until day 10. Moreover, to investigate the 
effect of c-Ets1 overexpression on modulation of inflamma-
tory proteins after instillation of IL-1  ,  specific  enzyme-linked 
immunosorbent assay (ELISA) kits were used (  Figure 4e ). The 
levels of inflammatory cytokines and the anti-inflammatory 
mediator, transforming growth factor (TGF)-  1, in the first BAL 
fluid were analyzed 3 days after IL-1     treatment. c-Ets1 over-
expression suppressed IL-1  -induced MIP2 and tumor necrosis 
factor (TNF)-     production, whereas shRNA-c-Ets1 expression 
increased the production of these proteins. Interestingly, TGF-  1 
was increased in BAL fluid collected from the c-Ets-infected 
mice. These results show that c-Ets1 could reduce mucous meta-
plasia and inflammatory cell recruitment in BAL fluid after IL-1   
treatment, suggesting that c-Ets1 functions as an important sup-
pressor in IL-1    -induced inflammation   in vivo .   
  ROS produced by NOX4 is essential for IL-1     -induced   c-Ets1   
gene expression in AMs 
 The c-Ets1 transcription factor induced  cytokine  and  chemokine  
gene expression to regulate inflammation in Ets-1 knockout 
mice.  21   However, little is known about a role for ETS factors 
in regulating inflammation in AMs. Accordingly, we investi-
gated whether c-Ets1 could regulate inflammatory cytokine gene 
expression in AMs. Mice were infected with viruses and killed 
3 days post IL-1     instillation. The AM cells obtained via BAL 
of the lungs harvested from the killed mice were subsequently 
incubated. c-Ets1 overexpression inhibited expressions of the 
  MIP2   and   TNF-       gene in AM cells, whereas shRNA-c-Ets1 
increased the expression of these genes (  Figure 5a ).  These 
results are consistent with those found for BAL fluid ( Figure 4e ). 
To examine whether IL-1     can produce ROS, flow cytometry 
              Figure 3                        c-Ets1 can downregulate   MUC5AC   gene expression by 
disrupting the interaction of NF-    B with cAMP response element-binding 
protein (CREB). (  a  ) Confluent cells were treated with interleukin (IL)-1     
(10    ng    ml        −      1  ) for the indicated times, then cell lysates were analyzed by 
Western blot with phospho-c-Ets1 antibody. Total c-Ets1 expression 
was used as a loading control. (  b  ) Cells were transiently transfected 
with either wild-type or the small interfering RNA (siRNA) construct of 
c-Ets1 or a siRNA control. Cells were serum-starved and treated with 
IL-1     (10    ng    ml        −      1  ) for 24    h, after which cell lysates were harvested for 
Western blot analysis and real-time PCR.   *    P        <      0.05 compared with 
the control;   *    *    P        <      0.05 compared with IL-1     treatment. (  c  ) Cells were 
transiently transfected with either the wild-type or the siRNA construct 
of c-Ets1 or a siRNA control. Cells were serum-starved and treated 
with IL-1     (10    ng    ml        −      1  ) for 30    min. Nuclear protein extracts from IL-1    -
treated NCI-H292 cells were subjected to electrophoretic mobility shift 
assay (EMSA). Nuclear proteins were incubated with [    -  32  P]-labeled 
CRE oligonucleotides or a 50-fold excess of cold CRE probe before 
EMSA. The labeled nuclear proteins were separated by electrophoresis 
on 5  %   polyacrylamide gels, and the gels were dried and exposed to 
autoradiography at       −      70  °  C overnight. (  d  ) Confluent and quiescent cells 
were transfected with either the wild-type or the siRNA construct of 
c-Ets1 or a siRNA control, then treated for 30    min with IL-1    . Total cell 
lysates were then immunoprecipitated with anti-c-Ets1 antibody and 
blotted with CREB antibody. IP: immunoprecipitation; IB: immunoblotting. 
Displayed figures are representative of three independent experiments.   MucosalImmunology | VOLUME 5 NUMBER 2 | MARCH 2012   211
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was used. ROS production was increased at 5   min and decreased 
at  10   min  ( Figure 5b  ). In addition, ROS production was unaf-
fected AM cell viability ( Figure 5c ). To determine whether IL-1   
induces a significant increase in the expression of NOX subtypes 
and to identify which NOX subtypes are involved in intracellular 
ROS production within AM cells, cells were treated with IL-1    
in a time-dependent manner and real-time PCR was performed. 
Interestingly, only  NOX4  gene expression increased significantly 
20   min  after  IL-1    treatment (  Figure 5d  ). We used siRNA  –
 NOX4 to verify the function of NOX4. Expression of the  c-Ets1  
and   Muc5ac   gene was inhibited by siRNA  –  NOX4 (  Figure 5e ). 
These results suggest that NOX4 is not only a critical NOX 
homolog in AM cells in response to IL-1    , but also is essential 
for IL-1  -induced intracellular ROS generation and expressions 
of both   c-Ets1   and   Muc5ac   g e n e .     
  DISCUSSION 
 This study was a detailed investigation of the negative regulation 
of the inflammation signaling mechanism, with special empha-
sis on the transcription factor c-Ets1. The   in vitro   and   in vivo  
studies showed that c-Ets1 regulates MUC5AC overproduction 
through at least two different pathways. These pathways include 
functioning as an activator binding to CREB after adenosine tri-
phosphate (ATP) treatment, and functioning as an attenuator.  9  
                    Figure 4                        c-Ets1 suppressed interleukin (IL)-1    -induced lung inflammatory responses   in vivo  . (  a  ) Lenti::c-Ets1, shlenti::c-Ets1, or lenti::luciferase 
(multiplicity of infection 30) was administered drop by drop to the right nostril. After 3 days, lungs from the killed mice were obtained and analyzed by 
Western blot with c-Ets1 antibody to determine the endogenous c-Ets1 expression level (  n        =      4). (  b  ) Three days after infection, 50        l of 200    ng of IL-1     
or saline was instilled inside the trachea, and 24    h later, the lungs were processed for PCR.   *    P        <      0.05 compared with saline-treated mice and   *    *    P        <      0.05 
compared with IL-1    -treated mice (  n        =      4). Figures shown are representative of three independent experiments. (  c  ) One week after IL-1     instillation 
(50        l of 200    ng) into the lumen of the trachea of mice infected with the virus encoding wild-type c-Ets1 or shRNA-c-Ets1, periodic acid-Schiff staining 
was performed in the lung (  n        =      4). (  d  ) Mice were infected with viruses and killed 3 days post IL-1     instillation (50        l of 200    ng), and lymphocytes, 
neutrophils, alveolar macrophages, and total protein levels in bronchoalveolar lavage (BAL) fluid were measured.   *    P        <      0.05 compared with saline-
treated mice and   *    *    P        <      0.05 compared with IL-1    -treated mice (  n        =      4). (  e  ) The levels of MIP-2, tumor necrosis factor (TNF)-    , and transforming growth 
factor (TGF)-    1 proteins in BAL fluid were measured using specific enzyme-linked immunosorbent assay kits.   *    P        <      0.05 compared with saline-treated 
mice and   *    *    P        <      0.05 compared with IL-1    -treated mice (  n        =      4).   212  VOLUME 5 NUMBER 2 | MARCH 2012 | www.nature.com/mi
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  The transcription factor interactions affect the positive  /
  negative regulation of the stimulant-induced expression of 
some genes. In our previous study, we found that the interac-
tion of CREB with c-Ets1 resulted in ATP-induced   MUC5AC  
gene expression,  9   suggesting that one or more transcription 
factor(s) are recruited by transcription factor complexes, because 
inflammatory conditions should increase stimulant-induced 
  mucin   gene expression. In fact, IL-1     can activate a number of 
transcriptional factors to induce many physiological phenom-
ena. However, there are few studies of the negative regulation 
mechanism  /  signaling of mucous hypersecretion with respect 
to IL-1   -induced   mucin   gene expression. Understanding the 
biochemical properties of protein  –  protein interactions in the 
alteration of signal transduction should provide further under-
standing of biological phenomena as well as additional insight 
into the signal transduction leading to the regulation of intra-
cellular signaling. It has been reported that either the NF-   B 
or CREB signaling pathways are essential for IL-1   -induced 
MUC5AC overexpression in the airway.  5,22   In this study, both 
pathways were found to function largely in MUC5AC over-
expression by interacting with each other and sharing the signaling 
required for complementation and augmentation to be properly 
performed in the respiratory tract. Nevertheless, the reason for 
this interaction remains unclear and the mechanism underlying 
negative regulation has yet to be clarified. Determining the way 
in which MUC5AC overexpression is either downregulated or 
suppressed to maintain homeostasis may support the develop-
ment of new therapeutic medication to control mucus over-
production. We, therefore, investigated a candidate protein for 
the downregulation of the interaction of NF-    B with CREB in 
the airway. 
  Until now, there have been a number of reports on IL-1   -
induced   MUC5AC   gene expression in the human airway. 
However, most of the studies on IL-1     have assumed it to be an 
upregulation mediator of inflammation when investigating intra-
cellular signaling pathways.  23,24  As many studies on the function of 
c-Ets1 in inflammation have focused on modulated physiological 
phenomena,  25,26  the negative effect of c-Ets1 on cytokine-induced 
mucus hyperproduction and mucous hypersecretion during 
inflammation remains unclear. With the exception of our previ-
ous study,  9  there have been no reports on c-Ets1-regulated mucin 
overproduction in the airway. We speculated that IL-1  -induced 
c-Ets1 activation can function as an intracellular suppressor by 
inhibiting several transcription factors in the airway as well as 
inhibiting cancer cell proliferation by binding to p53.  27,28  
 The most significant finding of this study is that c-Ets1 nega-
tively regulated IL-1   -induced  MUC5AC  overexpression  both 
  in vitro   and   in vivo   by dramatically disrupting the interaction 
of NF-    B with CREB (  Figure 3d  ). Previously, we reported that 
c-Ets1 functions as a co-activator of ATP-induced MUC5AC 
overexpression by binding to the ATP-activated CREB transcrip-
tion factor in the airway.  9  Thus, we wondered if c-Ets1 has a dual 
function or if it recruits negative factors to abolish intracellular 
signaling. Our results show that c-Ets1 regulates the dynamics of 
the interaction between NF-    B and CREB facilitated by IL-1   , 
which is supported by the finding that the c-Ets site (       −       930) is 
located very close to the NF-  B site (    −    956) 29  and the CREB site 
(    −    878) 5   in the   MUC5AC   promoter. Accordingly, we hypoth-
esized that c-Ets1 functions as an important suppressor of IL-
1    -induced MUC5AC overproduction, at least in part, in the 
airway epithelium. However, we found that binding of CREB to 
c-Ets1 for ATP signaling enhanced  MUC5AC  gene expression in 
NCI-H292 cells.  9  This discrepancy may be due to (1) secondary 
effects of signaling for c-Ets1 activation at the receptor level; (2) 
c-Ets1 functioning as a signaling conductor; or (3) differences in 
the type of stimuli because signal transduction may rely heavily 
on the interaction of stimulants with their own receptors or mol-
ecules. These conjectures indicate that even c-Ets1 with tran-
sient signaling capability may act as a signaling molecule by 
              Figure 5                        Effect of reactive oxygen species (ROS) produced by NOX4 
on c-Ets1 and   MUC5AC   gene expression in alveolar macrophage cells. 
(  a  ) Mice were infected with viruses and killed 3 days post interleukin 
(IL)-1     instillation (50        l of 200    ng), and alveolar macrophage (AM) cells 
from bronchoalveolar lavage fluid (  n        =      4) were incubated. After 24    h, 
real-time (RT)-PCR was performed with specific primers. (  b  ) The AM 
cells from saline-treated mice were pre-incubated in the presence of 
50      μ  M 2    ,7    -dichlorofluorescein diacetate for 30    min, and then exposed 
to IL-1     (20    ng    ml        −      1  ) for the indicated periods. Cell-associated 2    ,7    -
dichlorofluorescein levels were analyzed by flow cytometry.   *    P        <      0.05 
compared with saline-treated mice (  n        =      4). (  c  ) The AM cells from saline-
treated mice were pre-incubated in the presence of N-acetyl-cysteine for 
1    h in a dose-dependent manner, and then treated with IL-1     (20    ng    ml        −      1  ) 
for 1    h. A cell proliferation assay was performed with CCK-8 (Dojindo, 
Rockville, MD) (  n        =      4). (  d  ) The AM cells from saline-treated mice (  n        =      4) 
were exposed to IL-1     (20    ng    ml        −      1  ) for the indicated times, and then 
were performed RT-PCR with specific primers.  38   (  e  ) The AM cells from 
saline-treated mice (  n        =      4) were transiently transfected with either the 
small interfering RNA (siRNA) construct of NOX4 or a siRNA control. 
Cells were treated with IL-1     (20    ng    ml        −      1  ) for 24    h, and RT-PCR was 
subsequently performed. Representative results for more than three 
independent experiments are shown for each group.   MucosalImmunology | VOLUME 5 NUMBER 2 | MARCH 2012   213
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amplifying the signal, thus producing the correlated physiologi-
cal phenomena. Additionally, we suppose that activated c-Ets1 
may regulate the dynamics of the interaction between CREB 
and NF-  B, thereby negatively regulating mucous overproduc-
tion. Our hypothesis is supported by the finding that c-Ets1 
can bind to other transcription factors, such as AP-1, NF-   B, 
and the Pax family, in response to diverse signals.  10   However, 
the main difference between our findings and those previously 
reported in the literature is that we observed that c-Ets1 dis-
sociated the interacted NF-    B and CREB, thereby dissociating 
the protein complex to regulate mucus overproduction during 
airway inflammation. 
  More interestingly, c-Ets1 functioned as a negative regulator 
  in vivo   in the mouse lung model (  Figure 4b  ). We used mouse 
lungs, but not tracheas, to detect morphological differences 
largely in Muc5ac overproduction. We had difficulty detecting 
such differences using mouse tracheas after lipopolysaccharide 
instillation because the differences between the sham mice and 
the challenged mice were undetectable.  1   One possible reason 
for this finding was that the activator solution may have passed 
through the trachea without affecting mucus expression in the 
mouse tracheas. Thus, in the present study, lungs were selected 
in order to detect more dramatic morphological changes. 
Interestingly, IL-1    -induced mucous metaplasia, neutrophils, 
and AMs were decreased by c-Ets1, whereas shRNA-c-Ets1 
increased mucous metaplasia, suggesting that c-Ets1 functions 
as a negative regulator to maintain homeostasis by disrupting 
the interaction of NF-    B with CREB   in vivo  . However, it is still 
unclear whether c-Ets1 has consequences for IL-1   -induced 
mucous metaplasia and Muc5ac overproduction. Based on the 
results of our previous study  9  and the present study, c-Ets1 may 
influence physiological phenomena according to its role as a 
suppressor or activator in intracellular signaling. Even though 
such a result provides insight into the regulatory mechanism of 
mucus hyperproduction, an understanding of how c-Ets1 can 
regulate the amount of total protein, AMs, and neutrophils in 
BAL fluid is still unclear. In addition, if c-Ets1 functions in BAL 
fluid as well as   in vivo  , it may be related to apoptotic cell clear-
ance in acute lung injuries.  30  
  NOX4 is expressed predominantly in goblet cells in normal 
human nasal epithelial cells and might function in the induc-
tion of the expressions of both   MUC5AC   and   MUC8   gene. 31,32  
In addition, Lee   et al.  33   reported that NOX4 was expressed in 
human monocytes and mature macrophages. ROS activates the 
JAK  –  STAT pathway, which in turn contributes to goblet cell 
metaplasia, a major player in mucin production and airway 
clogging.  34  Recently, Severgnini  et al.  35  showed that ROS regu-
lates STAT activation in acute lung injuries. The importance of 
NOX4 for mucus hyperproduction and mucous hypersecretion 
is becoming increasingly apparent. In this study, we showed that 
siRNA – NOX4 decreased  c-Ets1  and  Muc5ac  gene expression in 
AM cells (  Figure 5e  ), suggesting that NOX may have critical 
functions in airway inflammation and may regulate ROS pro-
duction to maintain homeostasis in the airway. 
  Although MUC5AC was mainly expressed in epithelial cells 
and goblet cells, we found that lipopolysaccharide could induce 
  Muc5ac  gene expression in the mouse leukemic monocyte mac-
rophage cell line, Raw 264.7 (KSS, unpublished data). Thus, 
we postulated that Muc5ac is expressed in AM cells to induce 
inflammation or to affect the microenvironment. Fortunately, 
Muc5ac was expressed in cultured AM cells, suggesting that 
Muc5ac may cause an inflamed condition or recruit several 
inflammatory proteins or cells. Accordingly, expressed Muc5ac 
in AM cells may induce  /  regulate the inflammatory microenvi-
ronment. In addition, IL-1     induced   c-Ets1   and   Muc5ac   gene 
expression in AM cells through activation of NOX4. Although 
c-Ets1 inhibited MUC5AC overproduction ( Figures 3b and 4b ), 
there are three potential reasons for the induced expression of 
these genes, which have either an inflammatory function or a 
suppressive function. First, when inflammation is severe in the 
airway, suppressor proteins are overexpressed and inhibit mucus 
hyperproduction through c-Ets1  ’  s inhibitory function. Second, 
IL-1    induces more active MUC5AC gene expression than c-Ets1 
in order to increase mucus hyperproduction in inflammatory 
conditions. Third, IL-1   can induce production of the same levels 
of these proteins; however, some protein(s) abolish c-Ets1 gene 
expression. We assert that cells can regulate the balance between 
the production of these proteins to maintain homeostasis. 
  In conclusion, we found that the interaction of NF-   B  with 
CREB enhanced IL-1  -induced MUC5AC overproduction and 
the effect of the interaction was mutually additive. In addi-
tion, our findings showed that c-Ets1 could negatively regulate 
MUC5AC overproduction by inhibiting the protein  –  protein 
interaction both   in vitro   and   in vivo  , indicating that c-Ets1 
induces the reduction of mucous metaplasia, the number of 
AMs and neutrophils, and decreases MUC5AC overproduc-
tion. Moreover, ROS produced by NOX4 may transfer the sig-
nal to alter the inflammatory process  in vivo . Thus, these results 
suggest that c-Ets1 may be a potential therapeutic candidate to 
treat mucus hyperproduction by inhibiting the protein – protein 
interactions involved in MUC5AC overproduction.     
  METHODS   
  Materials.    IL-1   was purchased from R & D Systems (Minneapolis, MN). 
All antibodies were purchased from Cell Signaling (Beverly, MA), except 
the c-Ets1 antibody, which was purchased from Abcam (Cambridge, 
MA). The following siRNAs were synthesized by Bioneer (Daejeon, 
Korea): p65, 5   -GCCCUAUCCCUUUACGUCA(dTdT)-3  ;  CREB,  5  -
UCAAGGAGGCCUUCCUACA(dTdT)-3   ; c-Ets1, 5  -GCUGACCUC
AAUAAGGACA(dTdT)-3    ; murine NOX4, 5   -AACGAAGGGGUUA
AACACCUC(dTdT)-3    , and negative control, 5   -CCUACGCCACCA
AUUUCGU(dTdT)-3   .   
  Cell transfection.     For transfection, cells were plated in 6-well plates 
one day before transfection with plasmid DNA (1     g per well) or siRNA 
(100      pmole per well) using FuGENE HD (Roche; Indianapolis, IN) 
according to the manufacturer  ’  s instructions. Approximately 24     h after 
transfection, cells were maintained in 0.2  %   serum RPMI media for 
16 – 18   h before treatment with IL-1  , and then harvested.   
  Tracheotomy.     The 6- to 8-week-old C57BL  /  6 mice were maintained 
in accordance with the guidelines and under the approval of the 
Animal Care Committee of Kosin University College of Medicine, 
Busan, Korea. For intratracheal instillation, mice were anesthetized 
and their tracheas were surgically exposed by making an incision214  VOLUME 5 NUMBER 2 | MARCH 2012 | www.nature.com/mi
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in the neck skin. IL-1     solution  (200   ng  per  50      l) or saline (50        l) 
was injected into the exposed trachea using a microsyringe equipped 
with a 31-gauge needle. The skin was subsequently sutured, and 
the mice were killed, and their lungs were removed 24      h after 
infection.  36    
  Virus production and   in vivo   intranasal instillation for 
infection.      Vector constructions of   LentiM1.2::c-Ets1, shLentiM3.4::
c-Ets1, and shLentiM3.4::luciferase , and virus production were performed 
by Macrogen (Seoul, Korea). The sequences targeted were: sh-c-Ets1, 
5   -AGGTGTGGACTTCCAGAAG-3   and luciferase, 5  -CTTACGCTG
AGTACTTCGA-3   . Viral suspensions (multiplicity of infection 30) were 
administered drop by drop to the right nostril of the mice under anesthesia 
using gel-loading pipette tips.  37   Tracheotomies were performed 
3 days after infection.   
  PAS staining.      The mice lungs were fixed in 10  %   buffered neutral 
formalin, embedded in paraffin, and sectioned. For PAS staining, serial 
sections were collected on coated slides. The slides were treated with 
3  %   glacial acetic acid for 3     min, and then incubated with 0.5  %   periodic 
acid solution for 5     min, and then rinsed with phosphate-buffered saline 
buffer. The sections were then reacted with Schiff solution, washed in 
tap water, and counterstained with Harris hematoxylin.   
  BAL cells, primary cell culture, and ELISA.     BAL was performed by 
slowly injecting 1      ml of ice-cold phosphate-buffered saline, through 
the tracheal tube. The fluid was slowly obtained by gentle suction 
immediately after delivery, and cell counts were determined using an 
electronic Coulter Counter fitted with a cell sizing analyzer (Coulter 
Model ZBI with a channelizer 256; Coulter Electronics, Bedfordshire, 
UK).  30   Alveolar macrophages were isolated by adhesion (2      h) and 
cultured in serum-free X-Vivo 10 medium (BioWhittaker, Walkersville, 
MA). MIP-2, TNF-  , and TGF-   protein levels were measured from the 
first BAL fluid with specific ELISA kits (R & D systems).   
  Analysis of cellular ROS levels.     Cellular ROS levels were analyzed 
using the 2   ,7   -dichlorofluorescein assay. Cells were exposed to 50        M 
2   ,7   -dichlorofluorescein diacetate (DCFH-DA; Molecular Probes, 
Eugene, OR) for 30     min. The cells were washed and exposed to serum-
free media. After the specified incubation times, the cell-associated 
2   ,7  -dichlorofluorescein levels were analyzed by flow cytometry.   
  Other methods.    Other methods used in this study have been described 
previously.  1,2    
  Statistical analysis.      Data are presented as the means  ±  s.d. for at 
least three independent experiments. Where appropriate, statistical 
differences ere assessed by the Wilcoxon Mann  –  Whitney test. A   P -value  
  <    0.05 was considered statistically significant.      
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